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Abstract
Vascular malformations include several vascular abnormalities, congenital in most cases, classified according to
their dynamic flow characteristics into high-flow and low-flow abnormalities; both types are commonly located
in the head and neck region. Imaging modalities such as Echocolor-Doppler, CT, and MRI can be employed in
the evaluation of vascular malformations’ in order to describe their size, flow velocity, flow direction, and relationship
with the surrounding structures, and, even more important, to differentiate between different types of malformations,
since treatment modalities differ depending on their nature (low- vs high-flow).
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Background
The term “vascular malformations” includes a large num-
ber of vascular abnormalities, originally classified in 1982
by Mulliken & Glowacki [1]; a modified version proposed
in 1992 by Mulliken & Young is currently the widely used
classification to differentiate these malformations in clin-
ical and radiological practice [2] (Fig. 1).
Vascular malformations are congenital in most cases,
although not always evident. They usually develop dur-
ing childhood, increase their dimension following the
child growth and show no spontaneous regression. Their
growth can be exacerbated during puberty or pregnancy
due to hormonal changes, or as a result of thrombosis,
infection or trauma. Unlike other vascular abnormalities,
they can have an infiltrative behavior, involving multiple
tissue planes [3].
Vascular malformations are classified according to
their dynamic flow characteristics into high-flow (ar-
teriovenous malformations [AVM] and arteriovenous
fistulas [AVFs]) and low-flow abnormalities (venous,
lymphatic, capillary, capillary-venous, and capillary-
lymphatic-venous); the differential diagnosis between
these two groups plays a very important role in the pa-
tient management, since malformations with different
hemodynamic characteristics follow different treatment
pathways [4].
Both high- and low-flow vascular malformation are
commonly located in the head and neck region, with the
venous and lymphatic malformations ones being located
in this region in up to 40 and 80 % of cases respectively,
especially in the posterior cervical triangle [5]. AVM and
congenital AVF are also frequently localized in the cranio-
cervical region [6, 7].
Our purpose is to provide a comprehensive review on
management of cranio-cervical vascular malformations,
with a special focus on imaging and treatment and their
strong interdependency; more in detail, we want to de-
scribe the different treatment strategies, and the imaging
findings that the radiologists should report before treat-




They are usually classified into venous, lymphatic, capil-
lary and mixed abnormalities. A venous malformation
generally consists of small and large dysplastic thin-walled
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venous channels with variable amounts of hamartomatous
stroma, thrombi, and phleboliths, and appearing as a blue,
soft, non compressible, non pulsatile mass [8]. Lymphatic
malformations composed of chyle-filled cysts lined with
endothelium and can be divided into microcystic (multiple
cysts smaller than 2 mm) and macrocystic types (larger
cysts) [3]. Capillary malformations are areas of congenital
ectasia of thin-walled small vessels of the skin typically
confined to the dermis or mucous membranes and appear-
ing as cutaneous red discoloration; they might also be the
hallmark of complex anomalies such as Klippel-Trenaunay,
Sturge-Weber, and Parkes Weber syndromes [7]. Venous,
lymphatic and capillary components can be combined in
mixed low-flow malformations.
High-flow vascular malformations
AVFs are composed by a single vascular channel between
an artery and a vein, while AVMs consist of feeding arter-
ies, draining veins, and a nidus formed by multiple dys-
plastic vascular channels connecting arteries and veins,
with absence of a normal capillary bed, usually resulting in
an ill-defined mass.
Imaging features
Multiple imaging modalities should be employed in the
evaluation of vascular malformations’ characteristics,
such as size, flow velocity, flow direction, relationship
with the surrounding structures and lesion’s appearance
and content. US and Echo-Color Doppler usually repre-
sent the first imaging techniques to be used, at least in
case of superficial vascular lesions, allowing a real-time
visualization of arterial and venous flows and flow vel-
ocities’ measurement. Conventional radiography plays a
limited role, being especially useful in evaluating bone
(bone erosion or sclerosis, periosteal reaction, and
pathologic fracture). Multidetector Computed Tomog-
raphy (MDCT) permits to evaluate the enhancement
pattern of the lesion, thanks to its high temporal reso-
lution, and the presence of thrombosis or calcification.
Magnetic Resonance Imaging (MRI) is currently the
most valuable modality for the classification of vascular
anomalies, allowing to define the extension of vascular
lesions and their anatomic relationship to adjacent
structures without radiation exposure. Since a func-
tional analysis of the involved vessels is required for
treatment planning, the use of Dynamic time-resolved
MR angiography has become mandatory (TRICKs, GE
or, TWIST, Siemens). These sequences allow the acqui-
sition of images with high temporal and spatial reso-
lution, enabling a clear separation of the arterial inflow
from venous drainage and the detection of early venous
shunting, and providing information about the contrast
material arrival time and the flow direction [5, 9].
Low-flow vascular malformations
In MRI diagnosis of a low-flow malformation is based on
the absence of flow voids on SE images and lack of arter-
ial/early venous enhancement on post-contrast sequences;
low-flow malformations, especially venous malformations
typically show slow gradual filling with contrast material
[7, 10]. In case of hemorrhage or thrombosis, signal hetero-
geneity can be observed on T1-weighted images, whereas
the best sign for identification of a venous malformation is
the presence of phleboliths [7]. Delayed contrast-enhanced
sequence may demonstrate connections between the mal-
formation and the deep venous system, which can be use-
ful during treatment planning, since it can increase the risk
of deep venous thrombosis [3]. Lymphatic malformations
Fig. 1 Modified Mulliken classification for Vascular abnormalities (1992)
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are usually seen as lobulated, septated masses with high
signal intensity on T2-weighted sequences, usually with no
post-contrast enhancement in case of microcystic variants
and rim and septal enhancement in case of macrocystic
lesions. Imaging findings of mixed Malformation may
be non-distinguishable from those of venous malforma-
tions [3].
High-flow vascular malformations
MR imaging findings of high-flow malformations include
high-flow enlarged feeding arteries and draining veins,
appearing as flow voids on SE images or high-signal-
intensity foci on GRE images, usually as a poorly defined
mass. The dynamic enhancement of the AVM is generally
well assessed by using time-resolved dynamic 3D MR
angiography, with a contrast material rise time of 5–10 s,
tipically showing arterial feeders and early venous filling of
the lesion [5, 8, 10, 11].
Treatment
When planning the treatment of any vascular malforma-
tions it should be remembered that treatment must be
multidisciplinary involving several specialist such as plastic
surgeon, vascular surgeon, interventional radiologist and
dermatologist. Usually treatment indication is patient’s
complaint due to the lesion localization (unaesthetic) or
for functional (cramps due to stealing syndrome) or loco-
regional reason (compression of vital structure). Complete
eradication of the pathology is rarely achieved after the first
procedure; multiple treatment sessions are usually needed,
Fig. 2 29-year old female presenting with a venous malformation of the left malar region. a Post-contrast T1-weighted sequence shows partial filling of
the lesion with contrast material; (b) TRICKs sequence (MIP) mainly shows the venous drainage into the facial vein; (c) DSA images showing the procedure
of percutaneous sclerotherapy; (d) At post-treatment follow up the lesion shows a reduced enhancement on post-contrast T1-weighted images; (e)
Follow-up after a new sclerotherapy session: the lesion does not show any central filling, with a peripheral hyperenhancement due to reactive hyperemia
(post-contrast T1-weighted images, subtraction tecnique); (f) Late post-treatment follow-up with CT: the lesion has markedly reduced in size and shows
internal calcified foci, probably related to residual phleboliths
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even due to the natural tendency of treated vascular mal-
formations to recur. The aim of the treatment is to destroy
the nidus of the malformation. Depending on its nature
(low- or high-flow) treatment modalities differ [4, 8, 9, 12].
Low-flow malformation
Low flow malformations are treated percutaneously only if
not surgically removable. Due to their usual localization
within deep muscles, major surgery is needed to dissected
the entire nidus. Percutaneous route is preferred if the
nidus is reachable. The nidus is punctured under US guid-
ance or with blind technique (if clinically evident) with a
21 G butterfly needle. Prior to flebography esecution, dir-
ect back flow from the nidus should be obtained by gently
moving forward or withdrawing the needle tip. Then
digital subtraction angiography should be performed in
order to observe the anatomy of the nidus and its venous
drainage. Careful evaluation of the amount of contrast
media needed to opacify the nidus is required in order to
identify the correct amount of embolic agent to be
injected afterwards. Embolization can be performed only
if no direct flow to a drainage vein is seen. Otherwise, nee-
dle repositioning is mandatory. The procedure varies de-
pending on the embolic agent employed (atossisclerol vs
alchool) after deepening of the analgesia level. Atossi-
sclerol mousse requires less volume in comparison with
liquid alcohol, resulting in a moderate pro-thrombotic ef-
fect. Alchool provokes immediate thrombosis and edema
in the injected vessel by inducing protein denaturation, be-
ing more painful than atossisclerol. Antibiotic prophylaxis
and corticosteroids in the immediate post-procedural stay
are suggested [4, 8, 9, 12] (Fig. 2).
High-flow malformation
Different approaches are needed to treat an high flow vas-
cular malformation. Treatment options are trans-arterial,
trans-venous, or a combination of these with percutaneous
embolization. The aim of the treatment is always to obtain
exclusion of the nidus. Pre-procedural dynamic MRI helps
in choosing the best treatment modality to be used. Arterial
approach is usually performed via femoral approach with
selective catheterization of the nidus feeder. Microcatethers
Fig. 3 38 year-old male, with a vascular malformation of the right malar region; (a) Coronal fat-suppressed T2-weighted sequence showing a large
T2-hyperintense lesion of the malar region; (b, c) TRICKS sequence showing the very poor arterial component of the lesion and its gradual filling
with contrast material; (d) DSA performed before the sclerotherapy procedure; (e) Percutaneous sclerotherapy (f) The malformation was subsequently
treated with chemoembolization
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are required in order to perfom superselective embolization
with either glue, foam, particles or coils. Transvenous route
is employed when a too fast venous drainage could impair
embolic agent deposition within the nidus, thus leading to
non target embolization. Occlusion compliant ballons,
derived from neuro-intervention procedures, can be
used. Percutaneous adjunctive embolization could be
needed in case partial opacification or visualization of
the nidus are obtained during transvenous/transarterial
embolization [4, 8, 9, 12] (Fig. 3).
Post-procedural imaging
US and MRI are the most useful techniques to assess
treatment results and to plan the long-term management
strategy [9, 12]. Imaging technique employed during the
follow-up does not differ from the preoperative one in
terms of MRI protocol and technical aspects. There is no
consensus on timing for the first imaging evaluation after
the procedure in literature; at our Institution, post treat-
ment imaging follow-up timeline is usually scheduled
within 3 months after the treatment and therefore with
longer time interval. However, it is worthy to mention that
follow-up timeline could be modified in case of symptoms
recurrence.
Treatment-related complications could be minor or
major according to the impairment caused to the patient.
Minor complications include simple swelling of the treated
region, hematoma, partial nidus thrombosis, venous out-
flow thrombosis. Usually minor complications do not re-
quire longer hospitalization time nor adjunctive care. Major
complications are usually dependent on treatment modality
Fig. 4 34 year-old male, with an arterovenous malformation of the left aspect of the anterior cervical region; (a) Post-contrast T1-weighted sequence
shows a large lesion characterized by heterogeneous enhancement; (b) TRICKS sequence (MIP) showing the arterial feeders, mainly represented by
branches of the tireocervical trunk; (c, d) DSA images during the procedure showing the arterial component and the venous drainage of the lesion;
(e, f) Post-treatment CT images shows coils and residual post-contrast enhancement in the medial aspect of the lesion
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(percutaneous/ endovascular/ combined), on the agent
employed (glue, foam, alcohol, coils) and on the district
(cranio-facial being the more dangerous). Skin ulceration
could be the effect of a not perfect involved injection of em-
bolic agent within the nidus but in the surrounding sub-
cutaneous fat, or to a non target embolization. Nerve
paresis is usually due to non target embolization or either
compression by swelling of the embolized site and con-
comitant nerve compression [7–9].
Low-flow malformation
Ethanol causes almost instantaneous denudation of
endothelium with severe inflammatory reaction and
thrombosis [7]. Then fibrosis develops and the lesion
progressively shrinks. In order to accurately evaluate the
therapeutic response after sclerotherapy, the transient
inflammatory response needs to be resolved [13]. At
MRI, venous malformations after sclerotherapy demon-
strate an early high signal intensity related to the inflam-
matory reaction, associated with no enhancement in the
central portion of the treated lesion and peripheral
hyperenhancement due to reactive hyperemia [13]. After
few months the enhancement usually disappears and a
central scar appears as a dark area on both T1-and T2-
weighted images; a progressive shrinkage of the malfor-
mation is frequently observed [13, 14].
High-flow malformation
Since any incomplete treatment may stimulate the lesion’s
growth and the recruitment of new arterial feeders, the
treatment strategy must be planned with the aim of
achieving a complete eradication of the nidus [7]. After
transarterial embolization, thrombosis of the vascular
malformation should be seen; MR angiography may
show decreased/absent shunting and reduced/absent
venous system’s opacification. Any residual component
of the malformation must be treated in a second stage.
In some cases, Doppler US can be particularly useful
during the follow-up, especially in case of ferromag-
netic coils have been used; in these cases coils produce
artifacts at MRI and MDCT which can hinder an opti-
mal post-procedural evaluation of the malformation
[13] (Fig. 4).
Conclusions
Head and neck region represents one of the most com-
mon location for both high- and low-flow vascular malfor-
mations, observed in this region in up to 40 and 80 % of
cases respectively, especially in the posterior cervical tri-
angle. An accurate pre-procedural depiction of the malfor-
mation is mandatory in order to differentiate between
high- and low-flow abnormalities and therefore to guide
therapeutic decisions; imaging plays an addition role also
in the post-procedural follow-up of the treated lesions.
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